PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Clinical trials for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) explained in plain language.
Never miss a new study
Get alerted when new PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) trials appear
Sign up with your email to follow new studies for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New balloon treatment aims to keep leg arteries open
Disease control ENROLLING_BY_INVITATIONThis study looks at how well a special balloon coated with paclitaxel works for people with narrowed leg arteries. About 200 adults will be followed for a year to see if the balloon keeps the artery open and prevents the need for repeat procedures. The goal is to improve blood fl…
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 15:12 UTC
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study is following 300 people who had a procedure to open blocked leg arteries using a special balloon coated with a drug (paclitaxel) and vitamin E. The goal is to see if the balloon keeps the arteries open for at least a year without major problems like amputation or needi…
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC